Key Takeaways:
America-First Medicine Policy: Trump’s executive order prioritizes U.S.-made pharmaceutical ingredients to protect national security and strengthen domestic manufacturing.
Rebuilding the Reserve: The Strategic Active Pharmaceutical Ingredients Reserve (SAPIR) will be filled with a six-month supply of critical drug components, reversing Biden-era...
President Donald Trump’s Health and Human Services Department is pulling the plug on $500 million worth of mRNA vaccine projects — a bold shift that doubles down on skepticism toward Big Pharma’s favored technology.
Health Secretary Robert F. Kennedy Jr....
Key Takeaways:
5-Year Pilot Program: Starting as early as 2026, Medicaid and Medicare may opt to cover GLP-1 weight-loss drugs like Ozempic and Wegovy, expanding access beyond diabetes-related conditions.
Big Costs, Big Market: The drugs run up to $7,000 per year, with analysts...
Key Takeaways
Protecting Children: Paxton argues that AI chatbots posing as therapists risk deceiving kids into mistaking entertainment bots for real...
